Related Experiment Video
Updated: Oct 20, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycaemia increases mortality risk in non-diabetic patients with COVID-19 even more than in diabetic patients
Jennifer Morse1, Wendy Gay1, Kimberly M Korwek1
1Clinical Operations Group, HCA Healthcare, Nashville, TN, USA.
Insights
Hyperglycaemia, or high blood sugar, is a significant risk factor for COVID-19 mortality, even in patients without diabetes. Effective glucose control in hospitalized COVID-19 patients may reduce mortality risk.
Area of Science:
- Endocrinology
- Infectious Diseases
- Critical Care Medicine
Background:
- Diabetes mellitus is a known risk factor for severe COVID-19 outcomes.
- The role of hyperglycemia (high blood glucose) in COVID-19 mortality, irrespective of diabetes status, requires further investigation.
Purpose of the Study:
- To examine the association between hyperglycemia and COVID-19 severity and mortality.
- To determine if hyperglycemia independently predicts mortality in hospitalized COVID-19 patients, with or without a pre-existing diabetes diagnosis.
Main Methods:
- Retrospective analysis of 74,148 COVID-19 inpatients with recorded glucose measurements.
- Categorization based on pre-existing diabetes diagnosis and presence of hyperglycemic glucose values (>180 mg/dl).
- Statistical adjustment for age, BMI, admission severity, and oxygen saturation.
Main Results:
- Hyperglycemia was associated with substantially higher mortality rates in both diabetic (14.4%) and non-diabetic (21.7%) patients compared to those with normal glucose levels.
- After adjusting for confounders, hyperglycemia remained an independent predictor of mortality.
- The odds of mortality were significantly increased by hyperglycemia in both groups (OR 1.77 for diabetics, OR 3.07 for non-diabetics).
Conclusions:
- Hyperglycemia is an independent risk factor for mortality in hospitalized COVID-19 patients.
- Glucose control may be a modifiable factor to reduce COVID-19 mortality.
- These findings highlight the importance of monitoring and managing blood glucose levels in all COVID-19 patients.
Aim:
Diabetes has been identified as a risk factor for poor outcomes in patients with COVID-19. We examined the association of hyperglycaemia, both in the presence and absence of pre-existing diabetes, with severity and outcomes in COVID-19 patients.
Methods:
Data from 74,148 COVID-19-positive inpatients with at least one recorded glucose measurement during their inpatient episode were analysed for presence of pre-existing diabetes diagnosis and any glucose values in the hyperglycaemic range (>180 mg/dl).
Results:
Among patients with and without a pre-existing diabetes diagnosis on admission, mortality was substantially higher in the presence of high glucose measurements versus all measurements in the normal range (70-180 mg/dl) in both groups (non-diabetics: 21.7% vs. 3.3%; diabetics 14.4% vs. 4.3%). When adjusting for patient age, BMI, severity on admission and oxygen saturation on admission, this increased risk of mortality persisted and varied by diabetes diagnosis. Among patients with a pre-existing diabetes diagnosis, any hyperglycaemic value during the episode was associated with a substantial increase in the odds of mortality (OR: 1.77, 95% CI: 1.52-2.07); among patients without a pre-existing diabetes diagnosis, this risk nearly doubled (OR: 3.07, 95% CI: 2.79-3.37).
Conclusion:
This retrospective analysis identified hyperglycaemia in COVID-19 patients as an independent risk factor for mortality after adjusting for the presence of diabetes and other known risk factors. This indicates that the extent of glucose control could serve as a mechanism for modifying the risk of COVID-19 morality in the inpatient environment.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Related Concept Videos
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Hypoglycemia and Glucagon
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...